Overview
NEUP market data
Price History
NEUP price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.23 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.76 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 59.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.19 – $21.40 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $20.6M · P/B 0.70 · P/S 1.31.
Company News
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—NRIM, NEUP, SAFT, and RMAXGlobenewswire Inc · Jul 30, 2026, 4:15 PM
8-K filing — Neuphoria Therapeutics Inc. (NEUP)SEC EDGAR · Jul 23, 2026, 10:37 PM
12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga · Jul 23, 2026, 5:05 PM
Neuphoria Therapeutics shares are trading higher after the company announced it will be acquired by Scancell in an all-share merger.Benzinga · Jul 23, 2026, 2:48 PM
Neuphoria Therapeutics To Be Acquired By Scancell In All-Share Deal; Combined Company To Seek $89M In Debt And Equity Financing Upon U.S. ListingBenzinga · Jul 23, 2026, 10:16 AM
Scancell Issuing 20.4M ADSs (204.1M Consideration Shares) Representing 13.7% Of Enlarged Share Capital; Neuphoria Stockholders To Also Receive CVRs Linked To MilestonesBenzinga · Jul 23, 2026, 9:45 AM
Scancell Earlier Announced All-Share Merger To Acquire Neuphoria, Combined Company To Operate As Scancell, Apply To Trade On Nasdaq Under Symbol SCLTBenzinga · Jul 23, 2026, 9:40 AM
Neuphoria Therapeutics Confirms Discussions With Scancell Holdings About Potential Acquisition; Financial Terms UndisclosedBenzinga · Jun 26, 2026, 8:20 PM
Deal Dispatch: GoPro Retains Houlihan Lokey In Strategic Review, Brookfield Buys World Freight Company, YesCare Corp. BankruptcyBenzinga · May 15, 2026, 7:15 PM
HC Wainwright & Co. Downgrades Neuphoria Therapeutics to NeutralBenzinga · May 15, 2026, 5:34 PM